Published on in Vol 13 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/56067, first published .
Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project)

Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project)

Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project)

Steffen Flindt Nielsen   1, 2 , MD ;   Camilla Lundgreen Duus   1, 2 , MD ;   Niels Henrik Buus   2, 3 , MD, PhD ;   Jesper Nørgaard Bech   1, 2 , MD, PhD ;   Frank Holden Mose   1, 2 , MD, PhD

1 University Clinic in Nephrology and Hypertension, Gødstrup Hospital and Aarhus University, Herning, Denmark

2 Department of Clinical Medicine, Aarhus University, Aarhus, Denmark

3 Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark

Corresponding Author:

  • Steffen Flindt Nielsen, MD
  • University Clinic in Nephrology and Hypertension
  • Gødstrup Hospital and Aarhus University
  • Hospitalsparken 15
  • Herning, 7400
  • Denmark
  • Phone: 45 21278747
  • Email: stfnel@rm.dk